AR072803A1 - Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes - Google Patents
Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetesInfo
- Publication number
- AR072803A1 AR072803A1 ARP090102663A ARP090102663A AR072803A1 AR 072803 A1 AR072803 A1 AR 072803A1 AR P090102663 A ARP090102663 A AR P090102663A AR P090102663 A ARP090102663 A AR P090102663A AR 072803 A1 AR072803 A1 AR 072803A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- methyl
- hydrogen
- pyrazolyl
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- -1 1H-pyrazolyl Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
También reivindica proceso y composiciones farmacéuticas y uso para preparar medicamentos. Reivindicacion 1: Compuestos de la formula (1) en la que A es CRaRb o -CH2-CH2-; R1 es hidrogeno o alquilo; R2 es hidrogeno o alquilo; R3 es alquilo, cicloalquilo, cicloalquil-alquilo, arilo, arilo sustituido, 1H-pirazolilo o 1H-pirazolilo sustituido, dicho arilo sustituido es arilo sustituido de una a tres veces por sustituyentes elegidos con independencia entre alquilo, halogeno y haloalquilo, y dicho 1H-pirazolilo sustituido es 1H-pirazolilo sustituido de una a tres veces por sustituyentes elegidos con independencia entre alquilo y arilo; Ra es hidrogeno o metilo; Rb es hidrogeno o metilo; o Ra y Rb junto con el átomo de carbono al que están unidos forman un ciclopropilo, ciclobutilo o ciclopentilo; con la condicion de que si Ra y Rb son ambos hidrogeno o ambos metilo al mismo tiempo, entonces R3 sea (1-metil-ciclopropil) metilo; y las sales y ésteres farmacéuticamente aceptables de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08160446 | 2008-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072803A1 true AR072803A1 (es) | 2010-09-22 |
Family
ID=41050326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102663A AR072803A1 (es) | 2008-07-15 | 2009-07-14 | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8501940B2 (es) |
| EP (1) | EP2313375A1 (es) |
| JP (1) | JP5575762B2 (es) |
| KR (1) | KR20110036579A (es) |
| CN (1) | CN102089287B (es) |
| AR (1) | AR072803A1 (es) |
| AU (1) | AU2009272895A1 (es) |
| BR (1) | BRPI0915862A2 (es) |
| CA (1) | CA2730059A1 (es) |
| CL (1) | CL2011000061A1 (es) |
| IL (1) | IL209723A0 (es) |
| MX (1) | MX2011000226A (es) |
| PE (1) | PE20110207A1 (es) |
| RU (1) | RU2541533C2 (es) |
| TW (1) | TW201006802A (es) |
| WO (1) | WO2010006940A1 (es) |
| ZA (1) | ZA201009182B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| SG11201502527UA (en) * | 2012-10-05 | 2015-04-29 | Rigel Pharmaceuticals Inc | Gdf-8 inhibitors |
| TW201609665A (zh) * | 2013-11-05 | 2016-03-16 | 赫孚孟拉羅股份公司 | 作為ＲＯＲｃ調節劑的嗒衍生物 |
| CN107635971A (zh) * | 2015-05-04 | 2018-01-26 | 豪夫迈·罗氏有限公司 | 作为RORc调节剂的哒嗪衍生物 |
| CN107531669B (zh) * | 2015-05-04 | 2020-12-18 | 豪夫迈·罗氏有限公司 | 作为RORc调节剂的哒嗪衍生物 |
| WO2016177760A1 (en) * | 2015-05-04 | 2016-11-10 | F. Hoffmann-La Roche Ag | PYRIDAZINE DERIVATIVES AS RORc MODULATORS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1423381B1 (en) * | 2001-09-06 | 2007-01-03 | Schering Corporation | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| AU2003207717B9 (en) * | 2002-02-01 | 2009-05-07 | Merck & Co., Inc. | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| NZ534712A (en) * | 2002-02-19 | 2006-11-30 | Ono Pharmaceutical Co | Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| ATE469886T1 (de) * | 2002-11-18 | 2010-06-15 | Schering Corp | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen |
| JP4787321B2 (ja) * | 2005-07-05 | 2011-10-05 | エフ．ホフマン−ラ ロシュ アーゲー | ピリダジン誘導体 |
| RU2417989C2 (ru) | 2006-07-05 | 2011-05-10 | Ф.Хоффманн-Ля Рош Аг | ПРОИЗВОДНЫЕ АЛКИЛПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ 11β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ ТИПА 1 (11β-HSD1) |
-
2009
- 2009-06-25 US US12/491,278 patent/US8501940B2/en not_active Expired - Fee Related
- 2009-07-06 KR KR1020117000916A patent/KR20110036579A/ko not_active Ceased
- 2009-07-06 PE PE2011000019A patent/PE20110207A1/es not_active Application Discontinuation
- 2009-07-06 WO PCT/EP2009/058470 patent/WO2010006940A1/en not_active Ceased
- 2009-07-06 JP JP2011517854A patent/JP5575762B2/ja not_active Expired - Fee Related
- 2009-07-06 CN CN2009801275297A patent/CN102089287B/zh not_active Expired - Fee Related
- 2009-07-06 MX MX2011000226A patent/MX2011000226A/es active IP Right Grant
- 2009-07-06 EP EP09780161A patent/EP2313375A1/en not_active Withdrawn
- 2009-07-06 RU RU2011105058/04A patent/RU2541533C2/ru not_active IP Right Cessation
- 2009-07-06 BR BRPI0915862A patent/BRPI0915862A2/pt not_active IP Right Cessation
- 2009-07-06 CA CA2730059A patent/CA2730059A1/en not_active Abandoned
- 2009-07-06 AU AU2009272895A patent/AU2009272895A1/en not_active Abandoned
- 2009-07-13 TW TW098123640A patent/TW201006802A/zh unknown
- 2009-07-14 AR ARP090102663A patent/AR072803A1/es not_active Application Discontinuation
-
2010
- 2010-12-02 IL IL209723A patent/IL209723A0/en unknown
- 2010-12-21 ZA ZA2010/09182A patent/ZA201009182B/en unknown
-
2011
- 2011-01-11 CL CL2011000061A patent/CL2011000061A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110036579A (ko) | 2011-04-07 |
| US8501940B2 (en) | 2013-08-06 |
| US20100016325A1 (en) | 2010-01-21 |
| CA2730059A1 (en) | 2010-01-21 |
| CN102089287A (zh) | 2011-06-08 |
| IL209723A0 (en) | 2011-02-28 |
| JP5575762B2 (ja) | 2014-08-20 |
| TW201006802A (en) | 2010-02-16 |
| CL2011000061A1 (es) | 2011-07-01 |
| RU2011105058A (ru) | 2012-08-20 |
| MX2011000226A (es) | 2011-02-24 |
| JP2011528003A (ja) | 2011-11-10 |
| PE20110207A1 (es) | 2011-03-31 |
| EP2313375A1 (en) | 2011-04-27 |
| RU2541533C2 (ru) | 2015-02-20 |
| ZA201009182B (en) | 2011-10-26 |
| AU2009272895A1 (en) | 2010-01-21 |
| BRPI0915862A2 (pt) | 2015-11-03 |
| WO2010006940A1 (en) | 2010-01-21 |
| CN102089287B (zh) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
| CO7170163A2 (es) | Composiciones fungicidas | |
| UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
| AR089182A1 (es) | Derivados de aminopirimidina como moduladores de lrrk2 | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| CR20110370A (es) | Derivados de sulfonamida | |
| CR11241A (es) | Compuestos de pirazol y su uso como inhibidores de raf | |
| PA8828201A1 (es) | Compuestos triazina como inhibidores mtor y quinasa p13 | |
| AR068115A1 (es) | Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida | |
| UY31831A (es) | Derivados de indazoles sustituidos con fenilo o piridinilo | |
| UY32308A (es) | Nucleótidos uracil ciclopropílicos | |
| CR10034A (es) | Derivados de oxadiazol | |
| NI201000231A (es) | Inhibidores de ciclopropil polimerasa. | |
| AR091144A1 (es) | Compuestos inhibidores de la actividad de la catecol o-metiltransferasa | |
| MX2010001837A (es) | Derivados de 4-pirimidinasulfamida. | |
| ECSP13012600A (es) | CO-cristales y Sales de Inhibidores de CCR3 | |
| AR084152A1 (es) | Compuestos de triazolopirimidina como inhibidores de pde10a, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades del snc | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR065119A1 (es) | Compuesto de 2- oxo-1-oxa-3-azaespiro (4,5) decan-3-ilo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
| AR090557A1 (es) | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 | |
| AR077534A1 (es) | Derivados de isoxazol, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades relacionadas con el receptor gaba aalfa5 | |
| BR112014032229A2 (pt) | método para produção de 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il) piridina-2-carbonitrila, e intermediários da mesma | |
| AR085236A1 (es) | Compuestos de benzodioxol-piperazina como moduladores de los receptores 5-hty d | |
| AR071721A1 (es) | Derivados de piridil-prolinamida, composiciones farmaceuticas que los contienen y su uso para el tratamiento de ansiedad, depresion y trastornos del sueno. | |
| ECSP13012548A (es) | Inhibidores de oxadiazol de la producción de leucotrienos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |